Genetic variations of human papillomavirus type 16: implications for cervical carcinogenesis

Japanese Journal of Infectious Diseases
Iwao Kukimoto, Masamichi Muramatsu

Abstract

Human papillomaviruses (HPVs) are the causative agent of cervical cancer, and among approximately 15 high-risk genotypes, HPV16 accounts for more than half the cases of cervical cancer worldwide. Recent progress in determining HPV genomic sequences from clinical samples has revealed a wide variety in HPV16 genome sequences, and has allowed for comprehensive classification of intratype HPV16 variants. These consist of four variant lineages containing nucleotide variations in 1.0%-10.0% of the complete viral genome sequence. Epidemiological data suggest that the non-European-Asian lineages of HPV16 entail a higher risk of progression to invasive cervical cancer than the European-Asian lineage. Deep sequencing analysis has recently demonstrated that HPV16 genome sequences are highly homogeneous in individual clinical specimens compared with those of RNA viruses. However, an extremely sensitive PCR method, differential DNA denaturation PCR, has detected hypermutations from C to T or G to A in the E2 gene and the long control region of the HPV16 genome, which suggests the involvement of cellular apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC) proteins in this hypermutation. The quasispecies status of the HP...Continue Reading

References

Feb 22, 2001·Journal of the National Cancer Institute·A HildesheimR D Burk
Sep 6, 2001·Journal of the National Cancer Institute·J BerumenA Madrigal-de la Campa
Jun 5, 2002·Nature Reviews. Cancer·Harald zur Hausen
Feb 7, 2003·The New England Journal of Medicine·Nubia MuñozUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
Nov 2, 2004·Nature Reviews. Immunology·Reuben S Harris, Mark T Liddament
Jan 16, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Long Fu XiNancy B Kiviat
Jan 19, 2007·International Journal of Cancer. Journal International Du Cancer·Laura SicheroLuisa Lina Villa
Mar 28, 2008·Journal of the National Cancer Institute·Ana Cecilia RodríguezUNKNOWN Proyecto Epidemiológico Guanacaste Group
Jul 5, 2008·Genome Biology·Silvestro G Conticello
Aug 18, 2009·Public Health Genomics·Robert D BurkKoenraad Van Doorslaer
Aug 25, 2009·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·H B CaiX H Ding
Mar 9, 2010·Virology·Hans-Ulrich BernardEthel-Michele de Villiers
Oct 19, 2010·The Lancet Oncology·Silvia de SanjoseUNKNOWN Retrospective International Survey and HPV Time Trends Study Group
Feb 3, 2011·Molecular Biology and Evolution·Marc GottschlingIgnacio G Bravo
Apr 5, 2011·EMBO Reports·Sébastien LandryMatthew D Weitzman
Apr 30, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Tarik GheitSusanne K Kjaer
Jul 7, 2011·PloS One·Benjamin SmithRobert D Burk
Apr 12, 2012·Journal of Virology·Iris CornetUNKNOWN IARC HPV Variant Study Group
May 23, 2012·Cell·Serena Nik-ZainalUNKNOWN Breast Cancer Working Group of the International Cancer Genome Consortium
Jun 13, 2012·Microbiology and Molecular Biology Reviews : MMBR·Esteban DomingoCelia Perales
Sep 11, 2012·International Journal of Cancer. Journal International Du Cancer·Anne F RositchJennifer S Smith
Nov 22, 2012·British Journal of Cancer·I CornetG M Clifford
Jan 16, 2013·Cell Reports·Ludmil B AlexandrovMichael R Stratton
May 21, 2013·Virology·Ethel-Michele de Villiers
Jun 19, 2013·Virology·Koenraad Van Doorslaer
Jul 16, 2013·Nature Genetics·Michael B BurnsReuben S Harris
Jul 16, 2013·Nature Genetics·Steven A RobertsDmitry A Gordenin
Aug 16, 2013·Nature·Ludmil B AlexandrovMichael R Stratton
Sep 4, 2013·Virology·Robert D BurkZigui Chen

❮ Previous
Next ❯

Citations

Nov 29, 2016·The Journal of Investigative Dermatology·Yang YangXinghua Gao
Sep 26, 2019·Archives of Virology·Noé Escobar-EscamillaJosé Ernesto Ramírez-González
Dec 29, 2017·Virus Genes·Noé Escobar-EscamillaJosé Alberto Díaz-Quiñonez
Jul 3, 2018·Japanese Journal of Infectious Diseases·Trang Thi Thu PhamHiroshi Ichimura
Nov 19, 2020·Journal of Clinical Medicine·Justyna Pisarska, Katarzyna Baldy-Chudzik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.